financetom
Business
financetom
/
Business
/
PPL Plans $1 Billion Debt Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PPL Plans $1 Billion Debt Offering
Nov 19, 2025 5:01 AM

07:40 AM EST, 11/19/2025 (MT Newswires) -- PPL's (PPL) capital funding subsidiary said Wednesday it plans to offer $1 billion worth of exchangeable senior notes due 2030 in a private placement.

The PPL funding subsidiary said it intends to grant initial purchasers a 13-day option to purchase up to $150 million worth of additional notes.

The company said it intends to use net proceeds from the offering to pay down short-term debt and for general corporate purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
4D Molecular Therapeutics Receiving $11 Million in Funding for Cystic Fibrosis Study
4D Molecular Therapeutics Receiving $11 Million in Funding for Cystic Fibrosis Study
Oct 13, 2025
10:34 AM EDT, 10/13/2025 (MT Newswires) -- 4D Molecular Therapeutics ( FDMT ) said Monday that the Cystic Fibrosis Foundation is providing up to $11 million in additional funding to support development of 4D-710 to treat cystic fibrosis lung disease. The company said the first tranche of the funding, worth $7.5 million, closed in October. The second tranche will be...
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Oct 13, 2025
10:34 AM EDT, 10/13/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Monday its experimental gene therapy ABO-503 was accepted into the US Food and Drug Administration' Rare Disease Endpoint Advancement Pilot Program, which aims to speed up development of treatments for rare conditions. ABO-503 targets X-linked retinoschisis, a genetic eye disease that affects retinal structure and function. The...
Pacific Biosciences Says HiFi Technology Selected for South Korean Pangenome Project
Pacific Biosciences Says HiFi Technology Selected for South Korean Pangenome Project
Oct 13, 2025
10:33 AM EDT, 10/13/2025 (MT Newswires) -- Pacific Biosciences of California ( PACB ) said Monday that its HiFi sequencing technology has been selected as the primary platform for South Korea's pangenome reference project. The company said it will provide integrated sequencing services across the workflow under the project, an initiative led by Korea National Institute of Health to sequence...
Western Digital Expands SIT Lab For AI Boom
Western Digital Expands SIT Lab For AI Boom
Oct 13, 2025
Western Digital Corporation ( WDC ) shares are trading higher on Monday. The company announced the opening of its expanded System Integration and Test (SIT) Lab. The lab, spanning a 25,600-square-foot facility, is designed to accelerate customer adoption and deliver faster time-to-value. WDC is demonstrating strength. Get the inside scoop here. The new lab addresses growing AI storage demands by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved